FIELD: medicine.
SUBSTANCE: method for thrombocyte intravascular activation analysis involving blood sampling, blood cell fixation with ethylene-diamine-tetraacetic acid, centrifugation, and activated thrombocyte detection in the prepared plasma by maximum integrated optical density of all formed units, and if any observed, the intensity of thrombocyte intravascular activation is evaluated.
EFFECT: method provides higher accuracy of thrombocyte intravascular activation analysis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STUDYING THROMBOCYTE AGGREGATION | 2009 |
|
RU2421724C1 |
| ANTITHROMBOTIC PREPARATION AND METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS | 2002 |
|
RU2205027C1 |
| NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN | 2001 |
|
RU2302880C2 |
| METHOD OF DETERMINING AGREGATIVE ACTIVITY OF PLATELETS AND DEVICE FOR ITS REALISATION | 2008 |
|
RU2391665C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| METHOD OF EVALUATING THE EFFECTIVENESS OF NON-AGGREGATE PREPARATIONS AFFECTING THE METABOLISM OF ARACHIDONIC ACID BY INHIBITION OF CYCLOOXYGENASE-1 BOTH INDIVIDUALLY AND JOINTLY WITH ADP P2Y RECEPTOR ANTAGONIST ON PLATELET MEMBRANES OF THE BLOOD TO THE PATIENT RECEIVING NON-AGGREGATE PREPARATIONS | 2010 |
|
RU2442167C1 |
| VON WILLEBRAND FACTOR OR FACTOR VIII AND VON WILLEBRAND FACTOR FOR TREATMENT OF COAGULOPATHY, INDUCED BY PLATELET INHIBITORS | 2009 |
|
RU2563236C2 |
| PLATELET-SPECIFIC CHIMERIC IMMUNOGLOBULIN AND METHODS OF ITS USING | 1994 |
|
RU2158135C2 |
| APPLICATION OF VALSARTAN OR METABOLITE THEREOF FOR INHIBITION OF THROMBOCYTE AGGREGATION | 2003 |
|
RU2334512C2 |
| RGD-LIKE PEPTIDES | 2009 |
|
RU2396271C1 |
